Legacy Capital Group California, Inc. Argenx Se Transaction History
Legacy Capital Group California, Inc.
- $361 Billion
- Q2 2025
A detailed history of Legacy Capital Group California, Inc. transactions in Argenx Se stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 596 shares of ARGX stock, worth $474,964. This represents 0.09% of its overall portfolio holdings.
Number of Shares
596
Previous 446
33.63%
Holding current value
$474,964
Previous $264 Million
24.46%
% of portfolio
0.09%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
492Shares Held
28.1MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.97 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.22 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.04 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.55 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$936 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $44.1B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...